Trial Profile
Compassionate use of simeprevir in Europe for liver transplant recipients with recurrent Hepatitis C.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Daclatasvir; Sofosbuvir
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use